NVDA
54
2
AVGO
27
2
MCHP
43
-11
INTU
56
3
HIG
75
4
TAP
63
2
PFG
50
-2
AZO
53
3
BWA
48
-5
EXPD
48
-5
PLD
56
-5
PM
66
4
SIG
50
-5
CVX
46
8
ROK
64
-2
V
72
-4
HSIC
60
-2
PSA
63
2
O
24
2
CB
55
2
NVDA
54
2
AVGO
27
2
MCHP
43
-11
INTU
56
3
HIG
75
4
TAP
63
2
PFG
50
-2
AZO
53
3
BWA
48
-5
EXPD
48
-5
PLD
56
-5
PM
66
4
SIG
50
-5
CVX
46
8
ROK
64
-2
V
72
-4
HSIC
60
-2
PSA
63
2
O
24
2
CB
55
2
Financhill
Back

Match Group Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
50

MTCH
Match Group

Last Price:
32.49
Seasonality Move:
-0.89%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
137.02
Seasonality Move:
14.88%
Sell
50
Match Group (MTCH) is a Sell

Is Match Group a Buy, Sell or Hold?

  • The current Match Group [MTCH] share price is $32.66. The Score for MTCH is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • MTCH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MTCH Stock Price Chart

What is Match Group's stock price today?

  • The Match Group share price today is $32.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTCH is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

MTCH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.25 Sell
Relative Strength Index (14 RSI): 45.91 Sell
Chaikin Money Flow: 1995122 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.79 - 36.61) Sell
Bollinger Bands (100): (32.9 - 37.68) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

MTCH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.27 Buy
20-day SMA: 32.81 Sell
50-day SMA: 35.52 Sell
200-day SMA: 34.04 Sell
8-day EMA: 31.82 Buy
20-day EMA: 32.76 Sell
50-day EMA: 34.35 Sell
200-day EMA: 35.07 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Match Group Earnings Growth & MTCH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.37 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Match Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):